The clinical result of study of vaccine of the 1st generation of AIDS in China makes good progress

The clinical result of study of vaccine of the 1st generation of AIDS in China makes good progress
Cable of March 2 of www.chinanews.com Beijing (reporter Sun ZiFa) Chinese the intersection of Ministry of Science and Technology and great project office hold media's briefing and claim on national the intersection of science and technology and great project progress 2, " great infectious diseases such as AIDS and virus hepatitis,etc. are prevented and cured " National the intersection of science and technology and AIDS vaccine in the great project study and already make phased progress, up to the end of 2009, vaccine of the 1st generation of AIDS in China - -Recombinate the virus of vaccine (rTV) The clinical result of study of vaccine of AIDS makes good progress. Ministry of Science and Technology great project run, offer " the national the intersection of science and technology and great the intersection of project and 2009 annual report " of media reveal the same day, recombinate the virus of vaccine (rTV) The period of vaccine of AIDS divides going on at two stages as a, b. A stage result shows: The vaccine inoculation that experimenters have expected reacts, can tolerate rTV vaccine well, have not observed serious side reaction; Having finished being all tried and visited clinically and looking at at b stage, without serious bad incident, security is good. Vaccine that clinical trial needed of its �� stage has already been finished producing, is carrying on the appraisal of security, it is estimated that promotes the research of clinical trial of �� stage in the second half of 2010. It is reported, rTV vaccine is that the only progress reaches the duplication type carrier HIV vaccine at stage of clinical trials in the world at present. Meanwhile, the second generation of DNA vaccine, mucomembranous vaccine, the designs of vaccine carriers and the new vaccine antigen and innovative work of transformation have already been launched smoothly, make HIV vaccine of the second generation of China possess stronger technological advantage and competitiveness, have done talent's team and technological reserve well for the clinical experimental study at the next stage. In addition, rely on " great infectious diseases such as AIDS and virus hepatitis,etc. are prevented and cured " Special and other national plans of science and technology, 4 AIDS vaccine groups and 2 spontaneous organizations of person in charge of technological platform, more than 50 scientific research institutions, key universities and colleges, vaccine production unit have established the vaccine alliance of China's AIDS (CAVI) to unite the whole country ,Promote the exchange and cooperation of the vaccine field of China's AIDS, shared resource, intercommunication information effectively, intersectoral link launches the research of technique. " great infectious diseases such as AIDS and virus hepatitis,etc. are prevented and cured " Special new the intersection of hepatitis B and getting therapeutic vaccine, it demonstrates to be comparatively satisfied curative effect in being clinical in 243 the intersection of hepatitis B and �� stage of patient that finish already, under great project support, a clinical trial has already finished the recruiting of 517 cases of hepatitis B patient, among them 400 patients have finished the treatment of vaccine, it is estimated that finishes the registered clinical trial of this vaccine at the end of 2010. (End)

|